How Modern Australian Investors Split Their Money Between Local Shares and Global Crypto Platforms
Modern Australians are investing differently from previous generations. Many still begin with local shares because that’s the market they grew…
Tower Limited (ASX: TWR) Reports Record FY25 Profit – With a 9.5% Dividend Yield, Is It Time to Buy?
Tower Limited (ASX: TWR) just delivered something income investors rarely see – a 158% dividend surge backed by record profits.…
Locksley Resources (ASX:LKY) Starts Drilling at El Campo After $191M US Government Backing: Time to Buy?
Locksley Resources (ASX: LKY) has been one of the standout performers on the ASX this year, with shares up more…
Woodside Faces December Strike Vote at Pluto LNG 2: Is This 7% Yielder Still Worth Buying?
Woodside Energy (ASX: WDS) shares slipped this week as investors balanced mixed headlines: Australia’s Fair Work Commission has approved a…
Top 3 ASX Titanium Stocks Poised to Ride the Next Critical Minerals Boom
Why Titanium Could Be the Next Big Commodity For investors searching for the next wave of high-demand commodities with the…
Latitude66 (ASX: LAT) Jumps 38% as Laverton Deal Signals Evolution From Explorer to Developer
Latitude66 Soars 38% on Laverton Gold Acquisition, Marking Shift Toward Development Latitude66 (ASX: LAT) surged 38% today following the announcement…
Novonix’s Plan to Reignite Investor Confidence Beyond the Stellantis Setback
Refocusing After a Major Partnership Shock Novonix (ASX: NVX), like many critical mineral names, has faced a steep sell-off in…
Could the Droneshield controversy have been avoided? Here’s one possibility that could’ve reduced investor resentment over the share sales
The Droneshield controversy just won’t die. The executives who sold shares can apologise and explain themselves, but they cannot ‘unscramble…
This Phase 2 ASX Biotech stock is only at cash backing, but has enormous upside!
Phase 2 Biotech stocks on ASX tend to be capitalised at $40-110m, but Percheron Therapeutics (ASX:PER) is only at cash…
How to Spot an “Edge” in the Market Before the “House” Does
Being able to spot an “edge” is where you can identify bets that offer good value where the balance of…
Here’s why Enron collapsed, and the 5 key lessons investors need to takeaway
Some companies are practically synonymous with something, and the company that was known as Enron is synonymous with fraud. It…
Adobe (NDQ:ADBE): The 43-year old company behind PhotoShop and PDFs may have an even richer future ahead, driven by AI
Outside the so-called Magnificant Seven stocks, Adobe (NDQ:ADBE) is one of the most well-known by investors, as well as the…
Fisher & Paykel (ASX: FPH) Beats Expectations With 14% Revenue Growth: Time to Buy or Hold Off?
Fisher & Paykel Healthcare (ASX: FPH) jumped 8 per cent to $34.52 after delivering first-half results that comfortably beat market…
Harvey Norman (ASX: HVN) Hits Record High on 9% Sales Surge: Time to Take Profits or Ride the Momentum?
Harvey Norman Holdings (ASX: HVN) climbed 4% to a record high of $7.71 today after delivering a strong FY26 trading…
National Storage REIT Surges 19% as Brookfield Tables $2.86 Cash Offer
National Storage REIT (ASX: NSR) jumped 19% to $2.70 today after confirming it has received a $4.02 billion takeover proposal…